DC Circ. Opens Door For Stem Cell Regulation By FDA – Law360 (subscription)
|
DC Circ. Opens Door For Stem Cell Regulation By FDA
Law360 (subscription) Law360, New York (March 07, 2014, 5:02 PM ET) — When is the use of autologous stem cells in a medical procedure subject to regulation by the U.S. Food and Drug Administration? This question was at the forefront of a statutory injunction proceeding … |
